Correlation Between Deep Medicine and CF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Deep Medicine and CF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deep Medicine and CF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deep Medicine Acquisition and CF Acquisition VII, you can compare the effects of market volatilities on Deep Medicine and CF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deep Medicine with a short position of CF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deep Medicine and CF Acquisition.

Diversification Opportunities for Deep Medicine and CF Acquisition

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Deep and CFFS is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Deep Medicine Acquisition and CF Acquisition VII in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CF Acquisition VII and Deep Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deep Medicine Acquisition are associated (or correlated) with CF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CF Acquisition VII has no effect on the direction of Deep Medicine i.e., Deep Medicine and CF Acquisition go up and down completely randomly.

Pair Corralation between Deep Medicine and CF Acquisition

If you would invest  1,108  in CF Acquisition VII on September 10, 2024 and sell it today you would earn a total of  15.00  from holding CF Acquisition VII or generate 1.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy1.56%
ValuesDaily Returns

Deep Medicine Acquisition  vs.  CF Acquisition VII

 Performance 
       Timeline  
Deep Medicine Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Deep Medicine Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Deep Medicine is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
CF Acquisition VII 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CF Acquisition VII are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, CF Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Deep Medicine and CF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Deep Medicine and CF Acquisition

The main advantage of trading using opposite Deep Medicine and CF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deep Medicine position performs unexpectedly, CF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CF Acquisition will offset losses from the drop in CF Acquisition's long position.
The idea behind Deep Medicine Acquisition and CF Acquisition VII pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios